<DOC>
	<DOCNO>NCT00092196</DOCNO>
	<brief_summary>The purpose study determine efficacy tolerability investigational drug prevention chemotherapy-induced nausea vomit associate moderately emetogenic chemotherapy .</brief_summary>
	<brief_title>Study MK0869 Prevention Chemotherapy-Induced Nausea Vomiting ( 0869-071 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<criteria>Patient diagnosis breast cancer require treatment noncisplatin moderately emetogenic chemotherapy . Patient must complete participation main study protocol . Patient central nervous system malignancy . Patient receive radiation abdomen pelvis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Chemotherapy-Induced Nausea Vomiting</keyword>
</DOC>